Advertisement

Topics

China Sky One Medical Inc. Company Profile

00:47 EDT 18th July 2018 | BioPortfolio

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .


News Articles [2740 Associated News Articles listed on BioPortfolio]

IDS Medical Partners with Tencent to Distribute Medical Devices in China

IDS Medical Systems of Hong Kong formed a China JV with WeDoctor, the Tencent online healthcare portal, to provide an online supply chain that centralizes supply of medical devices and consumables. id...

Beijing's AK Medical Buys JRI Orthopedics of the UK for $24 Million

AK Medical Holdings, a Beijing orthopedic implant maker, paid $24 million to acquire JRI Orthopedics of the UK. Both companies make joint replacements. AK is the first company to obtain CFDA approval ...

Microbot Medical Announces Receiving a Notification of Granting a Patent Right for its ViRob Technology Platform in China

Microbot Medical (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that the State Intellectu...

Fountain Medical Development: Clinical trials, government involvement and China's future

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Joanne Jiang, Executive Vice President at Fountain Medical Development, a new contract research organisation in Chi...

Download Presentation : Healthcare in China – A Golden Investment Opportunity

What are the biggest drivers of China’s Total Healthcare Expenditure? Why is China’s healthcare industry robust and growing? How can one negotiate China’s healthcare reforms and chart their succ...

Medical Device Industry Could Be Hit Hard By Potential China Tariffs

A growing number of products, as well as their components, are now manufactured in China. One report estimated that if the proposed 25 percent tariffs took effect, the move could cost the medical devi...

Avita Medical Starts China Trial of "Spray-on Skin" for Burns

Avita Medical of Melbourne has started a China clinical trial of ReCell® to treat second-degree (deep partial-thickness) burns. ReCell is a device that harvests autologous cells, combines them wit...

20182023 China Orthopedic Splints Market Report Status and Outlook [Report Updated: 07032018] Prices from USD $3360

In 2017, the Orthopedic Splints market size was xx million USD in China, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In China market, the top players include DJO...

PubMed Articles [2826 Associated PubMed Articles listed on BioPortfolio]

Recent advances of medical foods in China: The opportunities and challenges under standardization.

Malnutrition with high incidence in hospitalized patients in China has brought a significant burden of disease. Although many clinical studies have demonstrated the importance of nutritional for patie...

Moving towards a better path? A mixed-method examination of China's reforms to remedy medical corruption from pharmaceutical firms.

Few studies have systematically examined the effects of the existing regulations for alleviating corruption in China. This study assesses the effectiveness of China's reforms to curb medical corruptio...

Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China.

China's universal medical insurance system (UMIS) is designed to promote social fairness through improving access to medical services and reducing out-of-pocket (OOP) costs for all Chinese. However, i...

Discussion on Administrative Innovation of Medical Device in China and U.S.

This article refreshes the innovative review approach of medical device in China at first. It proposes reference through presenting a series of existing review and approval of innovative medical devic...

Association between rural clinical clerkship and medical students' intentions to choose rural medical work after graduation: A cross-sectional study in western China.

A large number of programs have been implemented in many countries to increase the healthcare workforce recruitment in rural and remote areas. Rural early exposure programs for medical students have b...

Clinical Trials [2420 Associated Clinical Trials listed on BioPortfolio]

Realize the Current Situation of COPD Patients in China

This is a multi-centre, prospective, observational study to realize the current situation of COPD patients in China. About 5000 COPD patients will be enrolled from 50 participating sites a...

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

The purposes of the study are to analyse the cross-section data of secondary stroke prevention in China and to carry out a standard medical management including medicine and interactive ed...

National-wide Survey on Primary Health Care in China

The survey aims to support health policy making, this survey aims to comprehensively assess the capability and quality of PHC in different regions in China. The study is based on the China...

A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection(a Chinese Medicine Injection)Used in Hospitals in China

This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in February 2018. The purpose of this study is to make a monitoring...

SYNERGY China: Assess SYNERGY Stent in China

Prospective, multicenter, single-arm study, enroll 100 patients in no more than 10 sites across China, the primary endpoint is Technical success.

Companies [1697 Associated Companies listed on BioPortfolio]

China Medical Technologies

The China Medical Technologies Inc. is a high-tech enterprise specialized in R&D and manufacturing medical equipment and bio-medical products. The company was established in 1999, and was awarded ISO ...

China Yongxin Pharmaceuticals, Inc.

Founded in 1993, China Yongxin Pharmaceutical, Inc. is a vertically-integrated retailer and distributor of Chinese traditional medicines, pharmaceutical preparations, natural health products, heal...

China Yongxin Pharmaceutical, Inc.

Founded in 1993, China Yongxin Pharmaceutical is a manufacturer, retailer and distributor of Chinese traditional medicines, pharmaceutical preparations, natural health products, health food, cosme...

China SHESAYS Medical Cosmetology Inc.

China SHESAYS, founded in 2005, operates a chain of specialized medical cosmetology hospitals, clinics and skincare centers in Sichuan province. The Company has a full range of services including ...

China Aoxing Pharmaceutical Company, Inc.

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) is a pharmaceutical company located in China specializing in research, development, manufacturing and distribution of a variety of narcotics...

More Information about "China Sky One Medical Inc." on BioPortfolio

We have published hundreds of China Sky One Medical Inc. news stories on BioPortfolio along with dozens of China Sky One Medical Inc. Clinical Trials and PubMed Articles about China Sky One Medical Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of China Sky One Medical Inc. Companies in our database. You can also find out about relevant China Sky One Medical Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record